<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhai L</submitter><funding>the National Natural Science Foundation of China</funding><pagination>19</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12822331</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Intratumoral angiogenesis is crucial for the proliferation and metastasis of ovarian cancer. This study aims to comprehensively analyze the impact of angiogenesis-related genes on clinical outcomes, the immune landscape, and immunotherapy response in ovarian cancer.&lt;h4>Results&lt;/h4>Through integrated analysis of transcriptomic data from The Cancer Genome Atlas and Gene Expression Omnibus databases, we identified two novel angiogenesis subtypes that exhibited significant differences in clinicopathological features, prognostic outcomes, and tumor microenvironment characteristics. An angiogenesis-based risk score was developed, which effectively stratified patients into distinct risk groups. These groups demonstrated divergent clinical prognosis, immune cell infiltration pat</pubmed_abstract><journal>Journal of ovarian research</journal><pubmed_title>Integrative analysis and experiments to explore GAS1 as a prognostic target for ovarian cancer based on angiogenesis-related genes.</pubmed_title><pmcid>PMC12822331</pmcid><funding_grant_id>32471290</funding_grant_id><pubmed_authors>Huang D</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Zhai L</pubmed_authors><pubmed_authors>Zheng R</pubmed_authors><pubmed_authors>Zhu X</pubmed_authors><pubmed_authors>Liu R</pubmed_authors><pubmed_authors>He Q</pubmed_authors><pubmed_authors>Lin L</pubmed_authors><pubmed_authors>Fei J</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Integrative analysis and experiments to explore GAS1 as a prognostic target for ovarian cancer based on angiogenesis-related genes.</name><description>&lt;h4>Background&lt;/h4>Intratumoral angiogenesis is crucial for the proliferation and metastasis of ovarian cancer. This study aims to comprehensively analyze the impact of angiogenesis-related genes on clinical outcomes, the immune landscape, and immunotherapy response in ovarian cancer.&lt;h4>Results&lt;/h4>Through integrated analysis of transcriptomic data from The Cancer Genome Atlas and Gene Expression Omnibus databases, we identified two novel angiogenesis subtypes that exhibited significant differences in clinicopathological features, prognostic outcomes, and tumor microenvironment characteristics. An angiogenesis-based risk score was developed, which effectively stratified patients into distinct risk groups. These groups demonstrated divergent clinical prognosis, immune cell infiltration pat</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-06T19:20:37.146Z</modification><creation>2026-06-04T03:12:43.871Z</creation></dates><accession>S-EPMC12822331</accession><cross_references><pubmed>41408334</pubmed><doi>10.1186/s13048-025-01883-0</doi></cross_references></HashMap>